Recently, Wampler et al. monitored serum type I IFN activity, focusing on IFN-α and IFN-β activity using a functional reporter cell assay in RA patients just prior to them being treated with a TNF-α inhibitor [29]. The gene discussed is IFNA1; the disease is rheumatoid arthritis.